Cardiff Oncology Stock In The News
| CRDF Stock | USD 2.66 0.05 1.92% |
Our overall analysis of Cardiff Oncology's news coverage and content from conventional and social sources shows investors' bearish mood towards Cardiff Oncology. The specific impact of Cardiff Oncology news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Cardiff Oncology's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Cardiff Oncology headlines in addition to utilizing other, more conventional financial analysis modules. Check out Cardiff Oncology Backtesting and Cardiff Oncology Hype Analysis. For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.
Cardiff |
Cardiff Oncology Today Top News and Investor Outlook
Cardiff Oncology Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Cardiff and other traded companies coverage with news coverage. We help investors stay connected with Cardiff headlines for the 3rd of December to make an informed investment decision based on correlating the impacts of news items on Cardiff Stock performance. Please note that trading solely based on the Cardiff Oncology hype is not for everyone as timely availability and quick action are needed to avoid losses.
Cardiff Oncology stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Cardiff earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Cardiff Oncology that are available to investors today. That information is available publicly through Cardiff media outlets and privately through word of mouth or via Cardiff internal channels. However, regardless of the origin, that massive amount of Cardiff data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cardiff Oncology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cardiff Oncology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cardiff Oncology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cardiff Oncology alpha.
Cardiff Largest EPS Surprises
Earnings surprises can significantly impact Cardiff Oncology's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-08-05 | 2021-06-30 | -0.15 | -0.17 | -0.02 | 13 | ||
2024-05-02 | 2024-03-31 | -0.25 | -0.22 | 0.03 | 12 | ||
2023-03-02 | 2022-12-31 | -0.23 | -0.2 | 0.03 | 13 | ||
2021-02-25 | 2020-12-31 | -0.14 | -0.19 | -0.05 | 35 | ||
2023-11-02 | 2023-09-30 | -0.28 | -0.22 | 0.06 | 21 | ||
2022-11-03 | 2022-09-30 | -0.26 | -0.2 | 0.06 | 23 |
Cardiff Oncology Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Cardiff Oncology Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
19th of November 2024
Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating K... at gurufocus.com
7th of November 2024
Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update at finance.yahoo.com
9th of October 2024
Cardiff Oncology Inc Q2 2024 Earnings Call Highlights Strategic Trials and Financial ... at gurufocus.com
1st of October 2024
Acquisition by Pace Gary W of 29700 shares of Cardiff Oncology at 2.33 subject to Rule 16b... at MacroaxisInsider
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardiff Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardiff Oncology's short interest history, or implied volatility extrapolated from Cardiff Oncology options trading.
Check out Cardiff Oncology Backtesting and Cardiff Oncology Hype Analysis. For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiff Oncology. If investors know Cardiff will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiff Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.95) | Revenue Per Share 0.015 | Quarterly Revenue Growth 0.17 | Return On Assets (0.38) | Return On Equity (0.68) |
The market value of Cardiff Oncology is measured differently than its book value, which is the value of Cardiff that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiff Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cardiff Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiff Oncology's market value can be influenced by many factors that don't directly affect Cardiff Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiff Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiff Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiff Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.